Hemispherx Biopharma Appoints New Chief Financial And Chief Accounting Officers
Published: Dec 04, 2013
PHILADELPHIA, Dec. 4, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") today announced that the Board has appointed Thomas Equels as the new Chief Financial Officer and Adam Pascale as the new Chief Accounting Officer for Hemispherx Biopharma Inc. According to Mr. Equels, "With the recent departure of our prior Senior Vice President, who was largely responsible for both finance and market issues, and the recent resignation of our former CFO/CAO, we have an opportunity to restructure all of these functions with existing personnel. The Company is projected to significantly reduce expenditures with the restructuring and thereby achieve significant operational savings which will far better serve our missions in drug development. The Company is absolutely committed to the goals of stronger financial leadership, disciplined cost controls and a renewed commitment to creating shareholder value."
Help employers find you! Check out all the jobs and post your resume.